Skip to main content
OpenTrials

Clinical trial condition

Uterine Fibroids

Explore clinical trials studying Uterine Fibroids. Study availability and eligibility vary by location and protocol.

96 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Uterine Fibroids trial results

Completed

Post Market TRUST Study

NCT01563783

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +16 more
Locations
  • University of Saskatchewan, Saskatoon City Hospital Saskatoon, Saskatchewan, Canada
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

NCT03886220

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +15 more
Locations
  • ACCEL Research Sites /ID# 209714 Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Women's and Infant's Center /ID# 209581 Birmingham, Alabama, United States
  • Unity Health- Searcy Medical Center /ID# 210905 Searcy, Arkansas, United States
  • Grossmont Ctr Clin Research /ID# 217690 La Mesa, California, United States
View all 48 locations
View Trial Details
Completed

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

NCT02691494

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +16 more
Locations
  • Alabama Clinical Therapeutics, LLC /ID# 152258 Birmingham, Alabama, United States
  • Choice Research, LLC /ID# 150988 Dothan, Alabama, United States
  • Brown, Pearson, Guepet Gynecology /ID# 151020 Fairhope, Alabama, United States
  • Mobile, Ob-Gyn, P.C. /ID# 144294 Mobile, Alabama, United States
View all 105 locations
View Trial Details
Completed

An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT02925494

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +16 more
Locations
  • Alabama Clinical Therapeutics, LLC /ID# 153217 Birmingham, Alabama, United States
  • Alabama Clinical Therapeutics, LLC /ID# 153336 Birmingham, Alabama, United States
  • Choice Research, LLC /ID# 153492 Dothan, Alabama, United States
  • Brown, Pearson, Guepet Gynecology /ID# 153278 Fairhope, Alabama, United States
View all 124 locations
View Trial Details
Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT03070899

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +16 more
Locations
  • Site reference ID 192 Birmingham, Alabama, United States
  • Site reference ID 169 Dothan, Alabama, United States
  • Site reference ID 353 Mobile, Alabama, United States
  • Site reference ID 232 Vestavia Hills, Alabama, United States
View all 116 locations
View Trial Details
Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT03070951

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +16 more
Locations
  • Site reference ID 905 Chino, California, United States
  • Site reference ID 918 Huntington Park, California, United States
  • Site reference ID 902 San Diego, California, United States
  • Site reference ID 903 Denver, Colorado, United States
View all 96 locations
View Trial Details
Completed

Uterine Leiomyoma Treatment With Radiofrequency Ablation

NCT01840124

Conditions
Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • University of California, Davis Davis, California, United States
  • University of California, Irivine Irvine, California, United States
  • University of California, San Diego La Jolla, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View Trial Details

Related conditions